E
75.87
-0.57 (-0.75%)
| Penutupan Terdahulu | 76.44 |
| Buka | 76.62 |
| Jumlah Dagangan | 5,346,320 |
| Purata Dagangan (3B) | 3,831,981 |
| Modal Pasaran | 44,543,279,104 |
| Harga / Pendapatan (P/E TTM) | 41.92 |
| Harga / Pendapatan (P/E Ke hadapan) | 29.24 |
| Harga / Jualan (P/S) | 8.10 |
| Harga / Buku (P/B) | 4.71 |
| Julat 52 Minggu | |
| Tarikh Pendapatan | 22 Apr 2026 |
| Margin Keuntungan | 75.71% |
| Margin Operasi (TTM) | 29.01% |
| EPS Cair (TTM) | 2.42 |
| Pertumbuhan Hasil Suku Tahunan (YOY) | 6.20% |
| Pertumbuhan Pendapatan Suku Tahunan (YOY) | 1.70% |
| Jumlah Hutang/Ekuiti (D/E MRQ) | 6.86% |
| Nisbah Semasa (MRQ) | 4.45 |
| Aliran Tunai Operasi (OCF TTM) | 876.20 M |
| Aliran Tunai Bebas Leveraj (LFCF TTM) | 1.45 B |
| Pulangan Atas Aset (ROA TTM) | 8.42% |
| Pulangan Atas Ekuiti (ROE TTM) | 16.51% |
Arah Aliran Pasaran
| Jangka Pendek | Jangka Sederhana | ||
| Industri | Medical Devices (US) | Bercampur | Menurun |
| Medical Devices (Global) | Bercampur | Menurun | |
| Stok | Edwards Lifesciences Corporatio | Menaik | Menaik |
AISkor Stockmoo
1.4
| Konsensus Penganalisis | 5.0 |
| Aktiviti Orang Dalam | -3.5 |
| Volatiliti Harga | -1.0 |
| Purata Bergerak Teknikal | 2.5 |
| Osilator Teknikal | 4.0 |
| Purata | 1.40 |
|
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter aortic valves, and transcatheter mitral and tricuspid valve technologies. The firm derives about 60% of its total sales from outside the US. |
|
| Sektor | Healthcare |
| Industri | Medical Devices |
| Gaya Pelaburan | Mid Growth |
| % Dimiliki oleh Orang Dalam | 0.91% |
| % Dimiliki oleh Institusi | 89.29% |
| Julat 52 Minggu | ||
| Julat Harga Sasaran | ||
| Tinggi | 110.00 (Stifel, 44.99%) | Beli |
| Median | 100.00 (31.80%) | |
| Rendah | 87.00 (Canaccord Genuity, 14.67%) | Pegang |
| 87.00 (Baird, 14.67%) | Pegang | |
| Purata | 97.54 (28.56%) | |
| Jumlah | 9 Beli, 4 Pegang | |
| Harga Purata @ Panggilan | 82.34 | |
| Syarikat | Tarikh | Harga Sasaran | Panggilan | Harga @ Panggilan |
|---|---|---|---|---|
| BTIG | 11 Feb 2026 | 103.00 (35.76%) | Beli | 79.33 |
| Goldman Sachs | 11 Feb 2026 | 95.00 (25.21%) | Beli | 79.33 |
| Piper Sandler | 11 Feb 2026 | 100.00 (31.80%) | Beli | 79.33 |
| 20 Jan 2026 | 98.00 (29.17%) | Beli | 83.46 | |
| Truist Securities | 11 Feb 2026 | 89.00 (17.31%) | Pegang | 79.33 |
| Wells Fargo | 11 Feb 2026 | 100.00 (31.80%) | Beli | 79.33 |
| Stifel | 20 Jan 2026 | 110.00 (44.98%) | Beli | 83.46 |
| 07 Jan 2026 | 105.00 (38.39%) | Beli | 84.83 | |
| Barclays | 12 Jan 2026 | 104.00 (37.08%) | Beli | 83.01 |
| UBS | 12 Jan 2026 | 95.00 (25.21%) | Pegang | 83.01 |
| TD Cowen | 09 Jan 2026 | 97.00 (27.85%) | Beli | 85.13 |
| JP Morgan | 18 Dec 2025 | 100.00 (31.80%) | Beli | 84.80 |
| Canaccord Genuity | 17 Dec 2025 | 87.00 (14.67%) | Pegang | 84.84 |
| Baird | 16 Dec 2025 | 87.00 (14.67%) | Pegang | 85.32 |
| Citigroup | 11 Dec 2025 | 101.00 (33.12%) | Beli | 84.24 |
| Papar semua | ||||
| Nama | Purata Belian ($) | Purata Jualan ($) | Jumlah Net | Jumlah Nilai Bersih ($) |
|---|---|---|---|---|
| BOBO DONALD E JR | - | 85.29 | -35,340 | -2,990,221 |
| Jumlah Keseluruhan Kuantiti Bersih | -35,340 | |||
| Jumlah Keseluruhan Nilai Bersih ($) | -2,990,221 | |||
| Purata Pembelian Keseluruhan ($) | - | |||
| Purata Jualan Keseluruhan ($) | 85.29 | |||
| Nama | Pemegang | Tarikh | Jenis | Kuantiti | Harga | Nilai ($) |
|---|---|---|---|---|---|---|
| BOBO DONALD E JR | Pegawai | 02 Mar 2026 | Jual automatik (-) | 11,340 | 87.18 | 988,621 |
| BOBO DONALD E JR | Pegawai | 02 Mar 2026 | Pelaksanaan pilihan | 11,340 | - | - |
| BOBO DONALD E JR | Pegawai | 25 Feb 2026 | Jual (-) | 24,000 | 83.40 | 2,001,600 |
| Tarikh | Jenis | Butiran |
|---|---|---|
| 03 Feb 2026 | Pengumuman | Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026 |
| 02 Feb 2026 | Pengumuman | Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference |
| 09 Jan 2026 | Pengumuman | Edwards Comments on JenaValve Acquisition |
| 23 Dec 2025 | Pengumuman | FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy |
| 18 Dec 2025 | Pengumuman | Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference |
Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.
Portfolio
| Keuntungan Nyata | - |
| Keuntungan Tidak Nyata | - |
| Dividen Diterima 2026 | - |
| Jumlah Untung | - |
| Pulangan Purata | - |
| Kuantiti (Beli) | - |
| Purata Harga (Beli) | - |
| Kuantiti (Jual) | - |
| Purata Harga (Jual) | - |